What is the dose equivalent of dexmethylphenidate extended-release 30 mg to lisdexamfetamine (Vyvanse)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dose Conversion: Dexmethylphenidate ER 30mg to Vyvanse

There is no established direct dose equivalency between dexmethylphenidate ER 30mg and lisdexamfetamine (Vyvanse), as these are different medication classes (methylphenidate vs amphetamine) with distinct mechanisms and cannot be converted using a simple ratio.

Key Pharmacological Differences

These medications belong to fundamentally different stimulant classes:

  • Dexmethylphenidate ER 30mg: The active d-isomer of methylphenidate, dosed at half the typical d,l-methylphenidate dose due to single isomer formulation 1
  • Vyvanse (lisdexamfetamine): A prodrug that converts to dextroamphetamine after oral administration 2

Why Direct Conversion Is Not Possible

The 2026 Lancet Psychiatry network meta-analysis examining dose-effect relationships found that amphetamines and methylphenidate have different dose-response curves 3. Specifically:

  • Methylphenidate reached peak efficacy at approximately 45 mg/day (immediate-release equivalent)
  • Lisdexamfetamine showed a dose-effect relationship up to approximately 55 mg/day where effects plateaued 3

These distinct pharmacodynamic profiles mean you cannot apply a mathematical conversion factor between the two medications.

Clinical Approach to Switching

When transitioning from dexmethylphenidate ER 30mg to Vyvanse, start with Vyvanse 30mg and titrate based on clinical response 2. This approach is supported by:

  • Vyvanse is available in 10,20,30,40,50,60, and 70 mg doses 2
  • The therapeutic range for lisdexamfetamine is 30-70 mg daily 2
  • Starting at 30mg provides a conservative mid-range starting point that can be adjusted upward or downward

Important Caveats

  • Duration of action differs: Dexmethylphenidate ER provides 10-12 hours of benefit 1, while lisdexamfetamine provides 11-13 hours 1, 4
  • Onset differs: Lisdexamfetamine has approximately 2-hour onset due to prodrug activation 1, which may affect morning symptom control
  • Side effect profiles vary: Lisdexamfetamine may have higher rates of insomnia compared to methylphenidate formulations 5
  • Individual response is unpredictable: Studies show subgroups of patients respond differently to amphetamine versus methylphenidate classes, with some responding better to one class over the other 1

Monitor closely during the first 2-4 weeks after switching, as amphetamine-based medications may require several weeks to reach full therapeutic effect 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.